Fact-checked by Grok 2 weeks ago

Chelation

Chelation is a coordination chemical process in which a ligand, typically containing multiple donor atoms, forms two or more bonds to a single central metal ion or atom, thereby creating a heterocyclic ring structure that enhances complex stability compared to analogous monodentate ligands.^[1] This phenomenon, derived from the Greek word chele meaning "claw," underpins diverse applications in analytical chemistry for metal detection and separation, industrial processes such as water treatment and scale removal, and biological systems where metalloproteins rely on chelating ligands for enzymatic function.^[2] In medicine, chelation therapy employs synthetic agents like EDTA or DMSA to bind and excrete toxic heavy metals, proving efficacious in treating acute poisonings from lead, mercury, or iron overload, as evidenced by clinical protocols that reduce metal burdens and mitigate organ damage.^[3]^[4] However, off-label uses for chronic conditions like cardiovascular disease remain highly controversial, with systematic reviews concluding insufficient high-quality evidence of benefit beyond placebo effects, despite some proponent claims from smaller or methodologically limited trials.^[5]^[6]

History

Discovery of Coordination Chemistry

Alfred Werner laid the groundwork for coordination chemistry in 1893 with his seminal publication proposing the coordination theory, which differentiated primary valences (responsible for ionization) from secondary valences (determining coordination number and geometry in metal complexes).^[7] This framework explained the existence of geometric and optical isomers in compounds like cobalt(III) ammines, which defied earlier valence theories, and introduced the concept of fixed coordination geometries such as octahedral arrangements around the central metal ion.^[8] Werner's experiments involved synthesizing and resolving isomers of complexes like [Co(NH3)6]Cl3 and related species, demonstrating that ligands occupy specific positions around the metal, forming stable entities distinct from simple ionic salts.^[9] Werner's investigations extended to multidentate ligands, such as ethylenediamine and oxalate, where he observed the formation of cyclic structures—later termed chelate rings—that enhanced complex integrity compared to monodentate analogs.^[10] These rings arise from multiple donor atoms in a single ligand binding to the metal, creating a claw-like grip, a phenomenon he evidenced through solubility, precipitation, and isomerism behaviors that simple salts lacked.^[11] For instance, cobalt complexes with bidentate ethylenediamine exhibited greater resistance to ligand exchange and maintained optical activity, underscoring the structural rigidity imparted by ring formation.^[12] The term "chelate" was coined in 1920 by Gilbert T. Morgan and H. W. Drew to describe these pincer-like bindings, deriving from the Greek chele (χέλη), meaning "claw" or "lobster's pincer," emphasizing the multidentate grasp on the metal center.^[13] Morgan and Drew applied it to cyclic complexes like those of 8-hydroxyquinoline, noting their enhanced stability over non-cyclic counterparts through comparative solubility and dissociation studies in early 20th-century experiments.^[14] Werner's contributions culminated in the 1913 Nobel Prize in Chemistry, recognizing his foundational role in elucidating coordination compounds as precursors to chelation science.^[7]

Development of Synthetic Chelators

The synthesis of ethylenediaminetetraacetic acid (EDTA) in 1935 by Austrian chemist Ferdinand Münz marked a pivotal advancement in synthetic chelators, prepared via the reaction of ethylenediamine with chloroacetic acid under alkaline conditions to enable large-scale industrial removal of metal ions, particularly in textile processing.^[15]^[16] Münz's work, building on Alfred Werner's coordination theory, produced a hexadentate ligand capable of forming highly stable complexes with divalent and trivalent metals, facilitating applications in water softening and metal ion sequestration without precipitating unwanted hydroxides.^[17] This innovation addressed practical challenges in ion management, though initial patents were filed in Germany amid rising geopolitical tensions that later hindered Münz's recognition due to his Jewish heritage.^[15] During World War II, British chemists developed dimercaprol, known as British Anti-Lewisite (BAL), in the early 1940s as a dithiol chelator specifically to counteract the arsenic-based vesicant agent lewisite, forming stable, excretable thioarsinite esters to mitigate toxicity in potential chemical warfare scenarios.^[18]^[19] BAL's intramuscular administration enabled rapid chelation of arsenic, mercury, and other heavy metals, earning recognition as one of five major medical contributions from wartime research by reducing projected Allied casualties from exposure.^[19] Its structure, 2,3-dimercaptopropanol, exploited sulfhydryl groups for bidentate binding, though its volatility and toxicity limited broader use post-war.^[18] Post-1950 refinements focused on aminopolycarboxylic acids like diethylenetriaminepentaacetic acid (DTPA), an octadentate ligand synthesized in the mid-20th century to enhance specificity and stability over EDTA for sequestering actinides and radiometals, with initial applications in nuclear decontamination protocols.^[20] Similarly, meso-2,3-dimercaptosuccinic acid (DMSA, succimer) emerged as an oral, water-soluble analog to BAL in the late 1950s, offering reduced toxicity through its dicarboxylic acid framework while maintaining efficacy against lead and mercury via dithiol coordination, paving the way for ambulatory chelation therapies.^[21] These agents prioritized thermodynamic stability and biocompatibility, enabling targeted industrial and early antidotal uses without the parenteral constraints of predecessors.^[22]

Early Medical Applications

Edetate calcium disodium (CaNa₂EDTA) was approved by the U.S. Food and Drug Administration on July 16, 1953, for reducing blood and tissue levels of lead in cases of acute, chronic, and encephalopathic lead poisoning. This approval stemmed from animal experiments and initial human trials conducted in the late 1940s and early 1950s, which showed that intravenous CaNa₂EDTA administration increased urinary lead excretion by forming stable, water-soluble complexes that facilitated renal elimination, thereby lowering systemic lead burdens without excessive toxicity in controlled doses.^[23]^[24] Prior chelating agents, such as dimercaprol (British anti-Lewisite), had been developed during World War II as antidotes for arsenic and mercury exposure from chemical warfare, but CaNa₂EDTA represented an advancement in synthetic versatility for lead-specific toxicology. By the mid-1950s, it shifted toward standardized protocols for plumbism management, often combined with dimercaprol in severe encephalopathic cases to prevent lead redistribution to the central nervous system, enabling safer outpatient follow-up after acute intervention.^[25]^[26] Observational case series from the 1950s and 1960s in patients with confirmed elevated blood lead levels (>60 μg/dL at the time) reported chelation-induced reductions in symptoms of verified metal overload, including alleviation of colicky abdominal pain, hemolytic anemia, and peripheral neuropathy, with follow-up measurements confirming decreased lead mobilization via urine challenge tests. These findings, derived from clinical toxicology centers treating industrial and pediatric exposures, underscored empirical correlations between metal decoordination and symptomatic recovery in acute toxicities, though renal function monitoring was emphasized to mitigate hypocalcemia risks.^[3]^[27]

Chemical Fundamentals

Definition and Binding Mechanism

Chelation refers to the formation of two or more coordinate bonds between multiple donor atoms of a single polydentate ligand and a central metal ion or atom, resulting in a cyclic structure known as a chelate ring. According to the International Union of Pure and Applied Chemistry (IUPAC), this process involves bonds or attractive interactions from at least two binding sites within the same ligand molecule to one central atom, distinguishing it from coordination by monodentate ligands that form only single bonds per ligand. The ligand must be multidentate, with a minimum of bidentate capability, where donor atoms such as nitrogen, oxygen, or sulfur provide lone pairs to form dative covalent bonds with the metal's vacant orbitals.^[28] The binding mechanism begins with the approach and initial coordination of one donor group to the metal center, often displacing a solvent molecule or labile ligand from the metal's coordination sphere. This is followed by an intramolecular step where the second (or subsequent) donor atom closes the ring by binding to the same metal, constrained by the ligand's backbone chain length and flexibility.^[29] For optimal orbital overlap and minimal ring strain, the geometry favors five- or six-membered chelate rings, as larger rings introduce entropy penalties from increased flexibility, while smaller rings (e.g., three- or four-membered) suffer from bond angle distortions.^[29] A classic example is ethylenediamine (en, H₂N–CH₂–CH₂–NH₂), a bidentate ligand that forms a five-membered ring upon binding to transition metals like nickel(II) or copper(II).^[29] In this process, the ring closure step contrasts with the stepwise addition of two separate ammonia ligands: the intramolecular coordination releases solvated molecules more efficiently, driven by an increase in translational entropy as unbound ligands or solvents gain freedom, though the precise entropic contribution arises from the difference in molecular degrees of freedom between open-chain and cyclic forms._have_enhanced_metal_ion_affinity/3.1.2:The_Chelate_Effect(and_Macrocycle_Effect))

Chelate Effect

The chelate effect describes the enhanced thermodynamic stability of coordination complexes formed by multidentate ligands compared to those formed by an equivalent number of monodentate ligands. This phenomenon manifests in significantly higher formation constants for chelates, reflecting a greater affinity of the metal ion for the chelating agent.^[30] Quantitative evidence is provided by comparisons such as the nickel(II) ion with ethylenediaminetetraacetate (EDTA), where the overall stability constant log β for [Ni(EDTA)]^{2-} is approximately 18.6 at 25°C and ionic strength 0.1 M, whereas the stepwise formation of [Ni(NH_3)_6]^{2+} yields log β_6 ≈ 7.5 under similar conditions, indicating a stability enhancement of roughly 10^{11}-fold.^[31]^[32] The thermodynamic basis lies in the Gibbs free energy equation, ΔG^⊖ = ΔH^⊖ - TΔS^⊖, where the chelate effect is predominantly entropic. Ring formation releases solvent molecules or additional ligand particles from the coordination sphere, increasing the disorder of the system and yielding a positive ΔS^⊖ that favors the chelated product; enthalpic contributions (ΔH^⊖) are often comparable or slightly less favorable but outweighed by the -TΔS^⊖ term.^[14]^[33] Empirical verification of these stability differences has relied on potentiometric titration to measure pH-dependent equilibria and spectrophotometric methods to monitor spectral shifts indicative of complex formation, with systematic studies emerging in the mid-20th century through calorimetric and electrochemical techniques.^[34]^[30]

Thermodynamic Stability and Factors Influencing It

The thermodynamic stability of chelate complexes is quantified by overall formation constants β_n for the equilibrium M + nL ⇌ ML_n, where β_n = [ML_n]/([M][L]^n) and log β_n correlates with the standard Gibbs free energy change via ΔG° = -2.303 RT log β_n at 25°C.^[30] For bidentate ethylenediamine (en) with Ni(II), log β_3 ≈ 18.3, significantly higher than log β_6 ≈ 8.6 for hexammine, illustrating enhanced stability from chelation.^[30] Among first-row transition metal divalent ions, stability constants follow the Irving–Williams series: Mn(II) < Fe(II) < Co(II) < Ni(II) < Cu(II) > Zn(II), reflecting increasing ligand field stabilization energy and decreasing ionic radii up to Cu(II), with the latter's anomaly due to Jahn–Teller distortion favoring asymmetric coordination.^[35] Key factors include ligand denticity, where higher denticity strengthens binding through multiple interactions; chelate ring size, with five- and six-membered rings optimal (e.g., log β_3 = 17.83 for [Ni(en)_3]^{2+} versus 12.27 for six-membered 1,3-propanediamine analog), due to minimal strain; steric effects from bulky groups that hinder approach and reduce log β; and solvent polarity, as polar solvents solvate ions competitively but stabilize charged complexes via dielectric screening, with measurements typically in aqueous media at ionic strength 0.1–0.15 M.^[30]^[36] For aminopolycarboxylic acids like EDTA (H_4Y), protonation equilibria (pK_a1 = 1.99, pK_a2 = 2.67, pK_a3 = 6.16, pK_a4 = 10.26 at 25°C, I=0.1 M) compete with metal binding, yielding conditional constants K' = α_{Y^{4-}} β_4, where α_{Y^{4-}} ≈1 above pH 12 but drops sharply below pH 6.^[37] Speciation diagrams for Cu(II)-EDTA and Ni(II)-EDTA show the ML^{2-} species dominating between pH 4–10, with free metal or protonated forms prevalent at extremes; log β_4 values are 18.80 for Cu(II), 18.62 for Ni(II), and 18.00 for Pb(II) under similar conditions.^[38]^[31]

Natural Occurrence

Biological Chelators and Roles

In living organisms, endogenous chelators are primarily metalloproteins and small molecules that coordinate essential metal ions to enable functions such as oxygen transport, enzymatic catalysis, nutrient acquisition, and detoxification, thereby maintaining metal homeostasis against toxicity and deficiency. Hemoglobin, a tetrameric metalloprotein in erythrocytes, utilizes the porphyrin-based heme group to chelate ferrous iron (Fe²⁺), forming a stable complex that reversibly binds oxygen for systemic transport, with each heme binding one O₂ molecule under physiological conditions.^[39] This chelation prevents iron oxidation to the ferric state, which would impair oxygen delivery, and is conserved across vertebrates, as evidenced by sequence homology in globin genes.^[40] Bacteria and fungi produce siderophores, such as enterobactin in Escherichia coli, which are catechol-based ligands exhibiting formation constants exceeding 10⁵² for Fe³⁺, enabling solubilization and uptake of insoluble ferric iron in iron-scarce environments like host tissues.^[41] These chelators facilitate microbial virulence by supporting respiration and enzyme function, with siderophore biosynthesis pathways phylogenetically widespread among prokaryotes, indicating evolutionary adaptation to iron limitation.^[42] Zinc fingers, structural domains in eukaryotic proteins, coordinate Zn²⁺ via tetrahedral binding to two cysteines and two histidines (C₂H₂ type), stabilizing motifs for DNA-protein interactions in transcription factors like TFIIIA and catalytic roles in enzymes such as alcohol dehydrogenase.^[43] This chelation enhances structural rigidity, with dissociation constants around 10⁻¹³ M ensuring stability, and genomic analyses show over 700 such domains in the human proteome, conserved from yeast to mammals via orthologous genes.^[44] For detoxification, glutathione (GSH), a cysteine-containing tripeptide abundant in cells at millimolar concentrations, chelates soft heavy metals like mercury (Hg²⁺) and cadmium (Cd²⁺) through its thiolate, forming GSH-metal conjugates exported via ABC transporters, which reduces reactive oxygen species generation and cellular damage.^[45] This mechanism operates in prokaryotes and eukaryotes, with GSH depletion experiments confirming its causal role in metal tolerance, as mutants exhibit heightened sensitivity.^[46] Transferrin, a serum glycoprotein in vertebrates, binds Fe³⁺ with high affinity (K_d ≈ 10⁻²² M at neutral pH), sequestering it to avert Fenton chemistry-induced oxidative stress while enabling receptor-mediated delivery to tissues for heme and enzyme synthesis.^[47] Biochemical and phylogenetic studies reveal transferrin-like proteins in invertebrates, underscoring broad evolutionary conservation of chelation strategies for iron management across kingdoms.^[48]

Environmental and Geological Presence

Humic and fulvic acids, natural polydentate organic ligands derived from the decomposition of plant and animal matter, are ubiquitous in soils and aquatic systems where they form stable chelate complexes with trace metals including iron (Fe), copper (Cu), zinc (Zn), manganese (Mn), and cadmium (Cd).^[49] These complexes influence metal speciation, solubility, and bioavailability; for instance, fulvic acid enhances the availability of Fe, Mn, Zn, and Cu to plants by preventing precipitation and facilitating uptake, while humic acid can immobilize toxic metals like Cd, reducing their mobility in contaminated soils.^[50] ^[51] In natural waters, such chelation by humic substances modulates trace metal transport and partitioning between dissolved and particulate phases, with stability constants varying by pH and ligand concentration—typically log K values ranging from 10 to 15 for Cu-fulvic acid complexes.^[52] In marine environments, abiotic chelation plays a critical role in iron cycling, particularly in high-nutrient, low-chlorophyll (HNLC) regions where dissolved Fe is scarce due to its low solubility (approximately 0.01–1 nM total dissolved Fe).^[53] Natural organic ligands within dissolved organic matter (DOM), including humic-like substances and saccharides, bind Fe(III) to form stable complexes that inhibit hydrolysis and oxidation, thereby maintaining bioavailable Fe for phytoplankton primary production.^[54] These ligands, with conditional stability constants often exceeding log K' = 20–23, enable Fe uptake by marine algae even from strongly complexed forms, as demonstrated in bottle experiments where organically bound Fe supported growth rates comparable to free inorganic Fe.^[55] ^[56] Geochemically, chelate complexes contribute to metal mobilization during weathering and sedimentation processes, where low-molecular-weight organic acids like citrate—produced abiotically via mineral-organic interactions—solubilize metals from primary minerals, aiding their transport and deposition in secondary phases.^[57] In sediments, such complexes can stabilize trace metals against sulfide precipitation, preserving them in authigenic minerals; for example, Fe-organic chelates in anoxic porewaters influence diagenetic reactions, with evidence from redox studies showing enhanced metal retention linked to ligand-promoted dissolution.^[58] Fossil records indirectly reflect this through enriched trace metal signatures in organic-rich shales, attributable to ancient chelation stabilizing elements during deposition, though direct preservation of ligand-metal complexes is rare due to thermal degradation over geological timescales.^[59]

Industrial and Environmental Applications

Water Softening and Detergents

Chelating agents such as ethylenediaminetetraacetic acid (EDTA) and phosphonates sequester calcium (Ca²⁺) and magnesium (Mg²⁺) ions in hard water, forming stable, soluble complexes that inhibit the precipitation of scale-forming compounds like calcium carbonate and magnesium hydroxide.^[60]^[61] In boiler systems, this prevents deposition on heating surfaces, which would otherwise reduce heat transfer efficiency and increase energy consumption by up to 20-30% in severe cases.^[62] Phosphonates, in particular, serve as scale inhibitors by distorting crystal lattice formation, maintaining system integrity in industrial water treatment applications.^[63] In detergents and laundry formulations, chelators enhance cleaning performance by preventing metal ions from interacting with anionic surfactants, thereby avoiding the formation of insoluble soap scum that diminishes efficacy in hard water.^[64] EDTA, a synthetic aminopolycarboxylic acid, binds these ions with high affinity, allowing lower surfactant concentrations while achieving comparable soil removal, a practice widespread since EDTA's commercial adoption in detergents during the 1950s.^[65] Phosphonates complement this by stabilizing formulations against metal-catalyzed degradation, contributing to overall product stability and reduced dosing requirements.^[66] Environmental challenges stem from the persistence of EDTA, which resists biodegradation in aerobic wastewater treatment systems, with degradation rates often below 10% under standard conditions.^[67] This recalcitrance results in EDTA accumulation in receiving waters at concentrations up to several micrograms per liter, potentially increasing heavy metal mobility by complexing trace elements otherwise bound in sediments.^[68] Phosphonates exhibit variable biodegradability, with some hydrolyzing slowly in natural waters, prompting regulatory scrutiny and shifts toward alternatives like biodegradable polycarboxylates to minimize ecological risks.^[63]

Agriculture and Fertilizers

Chelated micronutrients such as iron (Fe) complexed with ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid) (EDDHA) and zinc (Zn) with ethylenediaminetetraacetic acid (EDTA) are incorporated into fertilizers to address soil deficiencies, particularly in alkaline conditions where free metal ions precipitate and become unavailable to plants.^[69]^[70] These synthetic chelates maintain metal solubility across a wide pH range, with Fe-EDDHA stable up to pH 11, enabling effective delivery in calcareous soils common in regions like the Mediterranean and parts of the U.S. Southwest.^[71] Field trials, including those on tomato crops, have demonstrated that chelated Fe applications increase fruit yield by 1.6 to 1.8 times compared to non-chelated sources, attributing gains to improved chlorophyll synthesis and reduced chlorosis.^[72] Similarly, Zn-EDTA enhances zinc uptake in deficient soils, supporting enzyme functions and crop growth, with efficacy confirmed in multi-year studies showing 15-25% yield improvements in affected crops like grapes and citrus.^[73]^[74] In livestock nutrition, chelated trace minerals—such as those formed with amino acids or proteinates—are added to feed to boost bioavailability over inorganic salts, as the ring structure protects ions from interactions with dietary antagonists like phytates and fibers.^[75] Common examples include chelates of copper (Cu), manganese (Mn), and Zn, which exhibit higher absorption rates; for instance, zinc amino acid chelates achieve up to 20-30% greater retention in ruminants compared to zinc sulfate.^[76] Regulatory frameworks, such as EU Regulation (EC) No. 1831/2003, authorize these additives with specifications limiting molecular weight to under 800 Da for chelates and requiring minimum metal-ligand ratios to ensure stability and efficacy.^[77] Dosage limits, e.g., 150-250 mg/kg feed for Zn chelates in pigs, prevent excess accumulation while optimizing performance metrics like growth rate and immune response in trials across poultry and swine.^[78]^[79]

Soil and Waste Remediation

Chelation plays a key role in soil remediation by enhancing the bioavailability of heavy metals such as lead (Pb) and cadmium (Cd), facilitating their extraction through plant uptake in phytoextraction processes. EDTA, a synthetic chelator, forms stable complexes with these metals, increasing their solubility and translocation from soil to harvestable plant biomass. Studies have demonstrated that EDTA application at dosages around 1.5–5 mmol/kg soil significantly boosts Pb and Cd accumulation in hyperaccumulators like Solanum nigrum and Portulaca oleracea, with extraction efficiencies reaching up to 20–30% for Cd in controlled pot experiments conducted in 2018–2019.^[80]^[81]^[82] Recent advancements emphasize biodegradable chelators as alternatives to EDTA to mitigate persistence in soil. Citric acid, a low-molecular-weight organic acid with chelating properties, has shown efficacy in post-2020 studies for heavy metal washing, particularly when combined with ultrasound assistance, achieving removal rates of 40–60% for Pb and Cd while degrading rapidly without long-term residue.^[83] Other agents like EDDS (ethylenediamine-N,N'-disuccinic acid) and GLDA (glutamic acid N,N-diacetic acid) outperform EDTA in biodegradability—EDDS degrades over 80% within 14 days—while maintaining comparable metal mobilization, with EDDS enabling 15–25% higher Pb extraction in field-like conditions.^[84]^[85] These alternatives reduce ecological risks, as EDTA's half-life exceeds decades, potentially prolonging contamination.^[86] In-situ flushing employs chelator solutions to mobilize contaminants for extraction via groundwater pumping, targeting sites with permeable soils. EPA evaluations of Superfund applications indicate EDTA flushing achieves 50–70% removal of metals like Cu, Pb, and Zn in pilot tests, though efficacy varies with soil hydrology and requires containment to prevent off-site migration.^[87]^[88] For instance, sewage-sludge-derived washing solutions with chelators removed up to 60% of spiked Cu (7875 mg/kg initial) and Pb (1414 mg/kg) in kinetic studies from 2021.^[88] Despite these benefits, chelation-based methods carry risks of remobilizing metals into deeper aquifers if flushing is incomplete, as EDTA complexes maintain solubility and can enhance leaching by 10–20 times compared to unchelated soils.^[86] Cost-benefit analyses reveal phytoremediation with chelators costs $50–200 per cubic meter, lower than excavation but offset by EDTA's expense ($10–50/kg) and need for recovery processes like evaporation-precipitation, which reclaim 75% of the agent but add operational complexity.^[89]^[90] Biodegradable options improve net benefits by avoiding secondary pollution, though overall remediation may require multiple cycles due to incomplete extraction (typically <50% in field scales).^[91]^[92]

Medical Applications

Treatment of Heavy Metal Toxicity

Chelation therapy serves as a standard intervention for confirmed cases of heavy metal toxicity, where agents are administered to form stable complexes with toxic metals, facilitating their renal excretion and thereby reducing systemic burden.^[93] This approach is reserved for verified poisonings, typically indicated by elevated blood or tissue metal levels exceeding clinical thresholds, such as blood lead concentrations above 45 µg/dL in adults or 70 µg/dL in children with symptoms.^[25] Primary agents include dimercaptosuccinic acid (DMSA, or succimer) for lead and mercury, calcium disodium edetate (CaNa₂EDTA) for lead, and deferoxamine for iron overload, with selection guided by metal type, acuity, and organ involvement.^[94] Efficacy is monitored via serial blood metal levels and 24-hour urinary excretion, which typically rises post-treatment, confirming mobilization and elimination.^[95] For lead poisoning, DMSA is the preferred oral agent for moderate cases, dosed at 10 mg/kg every 8 hours for five days followed by every 12 hours for 14-19 days, leading to significant increases in urinary lead excretion and transient reductions in blood lead levels by up to 50-70% in clinical studies.^[95] In severe acute cases with encephalopathy or blood lead exceeding 100 µg/dL, parenteral dimercaprol (3-4 mg/kg intramuscularly every 4-12 hours) is initiated, followed 4 hours later by CaNa₂EDTA (1-1.5 g/m² intravenously daily), a combination that enhances lead redistribution from tissues to urine while mitigating risks like cerebral redistribution.^[96] Randomized trials in lead-exposed children have demonstrated symptom resolution, such as abatement of abdominal pain and neuropathy, alongside normalized hematologic parameters, with urinary lead serving as a biomarker of response.^[25] Mercury toxicity, particularly from inorganic or elemental forms, responds to DMSA, which boosts urinary mercury excretion by approximately 65% and lowers blood levels at rates of 0.04 µg/L per day in treated patients.^[97] Administered orally at similar regimens to lead protocols, DMSA outperforms alternatives like penicillamine in safety and efficacy for both inorganic and organic mercury, as evidenced by animal models and human case series showing nephroprotection and reduced systemic symptoms.^[98] In chronic iron overload, such as from transfusions in thalassemia, deferoxamine is administered subcutaneously or intravenously at 20-50 mg/kg daily over 8-12 hours, achieving net negative iron balance and preventing complications like cardiac dysfunction in long-term studies spanning decades.^[99] Clinical trials report ferritin reductions and improved myocardial iron indices, with urinary iron excretion correlating to cumulative dose and confirming therapeutic chelation.^[100] Across these applications, protocols emphasize source removal prior to chelation to prevent rebound toxicity, with adverse effects like hypocalcemia or rash managed through monitoring.^[101]

Diagnostic and Therapeutic Agents

Chelators are integral to diagnostic imaging agents, particularly gadolinium-based contrast agents (GBCAs) used in magnetic resonance imaging (MRI). The ligand DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) forms highly stable macrocyclic complexes with Gd³⁺, such as gadoterate meglumine (Dotarem), with a thermodynamic stability constant (log K) of approximately 25.8, which prevents dissociation and release of toxic free gadolinium ions even in acidic or phosphate-rich environments.^[102] ^[103] This stability contrasts with less secure linear chelators like DTPA, reducing risks such as nephrogenic systemic fibrosis in patients with impaired renal function; macrocyclic agents like Gd-DOTA are thus prioritized in clinical guidelines for their inertness and safety profile.^[104] In positron emission tomography (PET) for oncology, zirconium-89 (⁸⁹Zr) chelators enable immuno-PET by stably binding the radionuclide to antibodies or peptides, leveraging its 78.4-hour half-life for prolonged tumor imaging. Traditional desferrioxamine (DFO) chelators suffer from suboptimal stability, leading to ⁸⁹Zr release and bone accumulation, but post-2018 innovations include sarcophagine derivatives and octadentate pseudopeptides that achieve near-quantitative labeling at room temperature and enhanced in vivo retention, as demonstrated in HER2-targeted breast cancer models.^[105] ^[106] These advancements support precise quantification of antigen expression and therapy response monitoring. Beyond diagnostics, chelators stabilize metallodrugs for targeted cancer therapies by modulating metal-ligand interactions to control reactivity and biodistribution. In platinum-based agents akin to cisplatin, bidentate chelating ligands such as ethylenediamine or pyridine derivatives form stable rings around Pt(II), slowing ligand exchange rates to minimize off-target nephrotoxicity while retaining DNA platination efficacy, with some analogs showing IC₅₀ values below 1 μM against resistant cell lines.^[107] ^[108] Similarly, non-platinum metallodrugs like ruthenium(III) complexes with polypyridyl chelators (e.g., RAPTA-type) exhibit selective tumor accumulation via protein transferrin binding, achieving preclinical tumor regression without the cross-resistance of cisplatin.^[109] These designs prioritize kinetic inertness to enhance therapeutic windows.^[110]

Nutritional and Feed Additives

Chelated minerals, particularly amino acid complexes such as zinc methionine (Zn-Met), are incorporated into livestock feed to enhance the bioavailability of essential trace elements compared to inorganic salts. Studies in broiler chickens have demonstrated that chelated zinc sources provide greater absorption and utilization, resulting in improved growth performance, even in diets with elevated calcium and phosphorus levels that inhibit inorganic mineral uptake. For instance, relative bioavailability of Zn-Met has been estimated at over 100% compared to zinc sulfate, supporting better feed efficiency and body weight gains in poultry and ruminants.^[111]^[112]^[113] Regulatory bodies, including the U.S. Food and Drug Administration (FDA), permit chelated trace minerals like zinc, copper, iron, manganese, and cobalt in animal feeds under provisions for food additives and generally recognized as safe (GRAS) status when used within specified limits to meet nutritional needs. Approvals are grounded in data showing enhanced animal performance, such as increased average daily gain and milk production in supplemented ruminants, without exceeding safe inclusion levels defined in 21 CFR Part 573. These additives are particularly valuable in intensive production systems where mineral antagonists in feed reduce inorganic salt efficacy.^[114]^[76] In human nutritional supplements, chelated minerals are marketed for potentially superior gastrointestinal absorption due to their organic ligand binding, which may mimic natural dietary forms; however, clinical evidence remains mixed, with stronger support for specific chelates like iron bisglycinate in improving hemoglobin levels than for broad-spectrum superiority over inorganic forms.^[115]^[116] Over-supplementation of chelated minerals in livestock can precipitate antagonistic imbalances, such as copper deficiency from excess zinc or molybdenum interference, potentially leading to reduced fertility, weight loss, or toxicity symptoms like alopecia and lameness in cattle. Proper formulation based on dietary analysis and regional soil mineral profiles is essential to avoid these risks, as excessive intake amplifies interactions not fully mitigated by chelation.^[117]^[118]

Chelation Therapy Controversies

Claims for Cardiovascular and Chronic Diseases

In the 1950s, clinicians treating lead poisoning with intravenous EDTA observed incidental improvements in angina pectoris and peripheral circulation among patients, prompting hypotheses that heavy metals and calcium deposits contribute to atherosclerotic plaque formation and vascular rigidity.^[119] Proponents posited that EDTA could selectively bind and remove these metals from arterial walls, thereby "decalcifying" plaques, reducing inflammation, and restoring vessel elasticity without surgical intervention.^[120] This idea gained traction through the 1960s and 1970s, with advocates linking environmental metal exposure to chronic arterial calcification and proposing repeated EDTA infusions—typically 20 to 40 sessions—as a non-invasive alternative to bypass surgery for coronary artery disease.^[121] Physicians such as Elmer Cranton advanced these claims in the late 20th century, arguing in publications that EDTA chelation reverses atherosclerosis by chelating calcium, inhibiting free radical production via iron removal, and improving endothelial function.^[122] Cranton's 1989 book Bypassing Bypass and subsequent editions of A Textbook on EDTA Chelation Therapy (updated through 2001) cited anecdotal reports of plaque regression, confirmed via angiography in select cases, and symptom relief in patients with occlusive vascular disease, positioning chelation as a broadly applicable therapy for preventing heart attacks and strokes.^[123] He advocated protocols combining EDTA with antioxidants and vitamins to enhance detoxification and mitigate oxidative stress purportedly underlying plaque stability.^[124] Alternative medicine proponents extend these assertions to chronic diseases beyond cardiovascular conditions, claiming chelation facilitates systemic detoxification of accumulated heavy metals, which they hypothesize exacerbate oxidative damage, inflammation, and metabolic dysfunction in ailments like diabetes, Alzheimer's, and arthritis.^[125] Such advocates assert benefits including enhanced energy, reduced joint pain, and slowed aging processes through metal removal and improved microcirculation, often integrating chelation into holistic protocols for "total body cleansing."^[126] These views, disseminated via practitioner networks and texts, emphasize EDTA's role in addressing "toxic burdens" from modern environments as a root cause of non-communicable diseases.^[120]

Empirical Evidence and Clinical Trials

The Trial to Assess Chelation Therapy (TACT), conducted from 2003 to 2011 and involving 1,708 patients with prior myocardial infarction, reported a modest 18% relative risk reduction in the primary composite endpoint of death, myocardial infarction, stroke, coronary revascularization, or hospitalization for angina when comparing edetate disodium (EDTA)-based chelation to placebo infusions over an average follow-up of 4.5 years.^[127] This overall effect was driven primarily by a subgroup of diabetic patients, who experienced greater event reduction (hazard ratio 0.60, 95% CI 0.39-0.91), raising concerns about subgroup artifacts and limited generalizability, as the trial faced recruitment challenges, high placebo crossover, and reliance on non-standard protocols.^[128] Subsequent meta-analyses, including one aggregating randomized data up to 2022, found no significant difference in cardiovascular outcomes between EDTA chelation and placebo across studies, attributing TACT's findings to potential biases in small, underpowered trials rather than causal efficacy.^[129] The TACT2 trial, a 2024 randomized, double-blind study of 1,000 patients with prior myocardial infarction, preserved renal function, and diabetes, tested EDTA chelation against placebo and found no reduction in the primary endpoint of cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina (hazard ratio 0.92, 95% CI 0.67-1.27; P=0.61) over a median 3.3-year follow-up, nullifying TACT1's subgroup signal and confirming lack of broad benefit in high-risk populations.^[130] This outcome aligns with prior descriptive meta-analyses questioning chelation's impact on surrogate markers like ankle-brachial index, emphasizing that apparent benefits in earlier, smaller studies likely stemmed from placebo effects or methodological flaws rather than removal of metals causally linked to atherosclerosis in non-toxic exposures.^[129] For neurodevelopmental and neurodegenerative conditions like autism spectrum disorder (ASD) and Alzheimer's disease, systematic reviews of randomized trials reveal no supporting evidence for chelation beyond heavy metal toxicity. A 2015 Cochrane review of pharmaceutical chelation for ASD, drawing from one small randomized crossover trial of oral dimercaptosuccinic acid (DMSA) in 65 children, reported no improvement in core symptoms (e.g., standardized mean difference -0.12, 95% CI -0.47 to 0.23 for behavior scales), underscoring risks without efficacy and the absence of larger confirmatory data.^[131] Similarly, no high-quality randomized trials demonstrate chelation's benefit for Alzheimer's, with empirical data limited to preclinical or anecdotal reports overshadowed by biases in proponent-led studies; large-scale assessments prioritize null findings from controlled settings over unverified claims of metal detoxification reversing cognitive decline.^[132] These patterns highlight how small, non-replicated studies prone to expectation biases fail to withstand scrutiny from rigorous, placebo-controlled evaluations.

Risks, Side Effects, and Regulatory Scrutiny

Chelation therapy, particularly with agents like EDTA, carries significant acute risks, including hypocalcemia that can precipitate cardiac arrest and death. Between 2003 and 2005, three fatalities were reported to the Centers for Disease Control and Prevention due to hypocalcemia-induced cardiac arrest during EDTA administration, often exacerbated by rapid infusion rates or concurrent use of other calcium-binding agents.^[133] ^[134] Renal toxicity is another acute concern, with EDTA capable of causing acute kidney injury or failure, especially in patients with preexisting renal impairment or dehydration, as documented in clinical reviews of chelation adverse events.^[24] ^[95] Long-term side effects from repeated chelation courses include essential mineral depletion, such as zinc, copper, and magnesium, which can lead to nutritional deficiencies, anemia, or impaired immune function if not supplemented adequately.^[135] ^[136] Venous complications, including phlebitis, thrombosis, or sclerosis from repeated intravenous access, have been observed, contributing to vascular damage over multiple sessions.^[137] ^[138] Regulatory bodies have issued repeated warnings against off-label uses of chelation for conditions like cardiovascular disease, where it lacks approval. The U.S. Food and Drug Administration (FDA) has stated that no chelation products are approved for over-the-counter use or for treating heart disease, emphasizing risks of harm from unmonitored administration; in 2010, the FDA targeted eight companies marketing unapproved chelation products, citing violations of federal law and potential for severe injury or death.^[139] ^[140] Such off-label protocols often involve costly regimens—typically $75 to $300 per intravenous session, with full courses of 20 to 40 treatments exceeding $5,000—which divert resources from established therapies without corresponding regulatory endorsement for non-toxic metal indications.^[141] ^[142]

Reversal Processes

Dechelation Mechanisms

Protonation of chelating ligands in acidic environments competes with metal coordination by occupying donor atoms, thereby destabilizing the complex and promoting metal ion release. For ethylenediaminetetraacetic acid (EDTA) complexes, acid hydrolysis proceeds via stepwise protonation of carboxylate and amine groups, with kinetics showing pseudo-first-order dependence on hydrogen ion concentration; for vanadium(V)-EDTA, the rate constant at 25°C and ionic strength 0.5 M is reported as facilitating measurable dissociation over hours to days depending on pH.^[143] ^[144] This mechanism is general for polyaminocarboxylate chelators, where low pH shifts equilibria toward free ligand and aquated metal, as the stability constants decrease sharply below pH 3 due to reduced ligand basicity.^[145] Ligand exchange via competing species with higher affinity for the metal can displace the original chelator, often accelerated by excess competitor concentration. In EDTA systems, sulfide ions (e.g., from Na₂S) precipitate metals like cadmium, effectively reversing chelation through formation of insoluble sulfides while regenerating EDTA, with efficiency peaking at pH 4–10.^[146] Redox processes alter metal oxidation states to weaken binding; for instance, in ferritin, reduction of stored Fe(III) to Fe(II) by flavin nucleotides or thiols triggers iron mobilization through dedicated protein channels, as the ferrous form exhibits lower affinity for the ferroxidase center and mineral core, with release rates increasing by orders of magnitude in the presence of reductants like FMN.^[147] ^[148] Kinetic inertness arises from high activation barriers in dissociative pathways, where ring strain and multi-dentate constraints slow bond breaking compared to monodentate analogs; lanthanide-DOTA chelates, for example, exhibit half-lives for acid-catalyzed dissociation exceeding years at pH 1, reflecting the chelate effect's role in enforcing temporary stability despite thermodynamic potentials for reversal.^[149] These barriers underscore why dechelation often requires external triggers like protonation or redox to achieve practical timescales, as unimolecular dissociation remains negligible without them.^[150]

Practical Methods and Challenges

In laboratory settings, acidification serves as a primary method for dechelation, particularly for EDTA-metal complexes, by protonating the ligand's carboxylate groups at pH 2–3, thereby destabilizing the coordination bonds and releasing metal ions such as cadmium or copper for recovery via precipitation as sulfides or hydroxides.^[151]^[146] The freed EDTA can then be recovered through neutralization and reuse, as demonstrated in soil-washing effluents where acidification preserved the ligand's extraction efficacy comparable to fresh EDTA.^[151] Dialysis, utilizing semipermeable membranes, facilitates separation of chelate complexes from unbound species in analytical or preparative protocols, though its utility is limited for tightly bound chelates due to comparable molecular weights and diffusion rates, often requiring extended equilibration times or affinity variants with selective polymers.^[152] In medical contexts, such as gadolinium-based contrast agent overdose, acidification or dialysis may aid in partial reversal, but free metal ions pose acute toxicity risks if not fully sequestered post-release.^[153] For environmental remediation, post-2020 developments emphasize photocatalytic approaches, where semiconductors like TiO₂ or ZnO under visible or UV irradiation oxidize chelator ligands (e.g., EDTA), liberating heavy metals for electrochemical recovery or adsorption, achieving up to 90% degradation in wastewater matrices while minimizing secondary pollution.^[154] Enzymatic methods remain niche, primarily explored in bioremediation via metalloenzymes mimicking Mg-dechelatases for chlorophyll analogs, but scalability lags due to substrate specificity and low throughput for synthetic chelates like DTPA.^[155] Key challenges include incomplete dechelation, where residual complexes retain environmental mobility and bioaccumulation potential, leading to prolonged toxicity—e.g., unchelated gadolinium ions disrupt calcium-dependent processes, exacerbating nephrotoxicity.^[156]^[153] In remediation, suboptimal pH control or light intensity can yield partial ligand breakdown, releasing bioavailable metals into effluents and necessitating downstream capture steps, while high energy demands and chelator degradation byproducts hinder cost-effectiveness.^[157] Selectivity issues further complicate multi-metal systems, as competing ions reduce recovery yields below 80% in complex waste streams.^[157]

References

[1]
Some Linguistic Detail on Chelation | Journal of Chemical Education
The term chelate was first applied by Morgan and Drew in 1920 to describe the heterocyclic rings formed from bidentate ligands bonding to a central atom.Missing: definition | Show results with:definition
[2]
Chelating Agents in the Oilfield - IntechOpen
Chelating agents are compounds having at least two groups, usually referred to as ligators, that can transfer electrons to generate coordination bonds with a ...1. Introduction · 2. Apcas For Mineral... · 4. Inorganic Scale Removal
[3]
Chelation in Metal Intoxication - PMC - PubMed Central - NIH
Chelation therapy is the preferred medical treatment for reducing the toxic effects of metals. Chelating agents are capable of binding to toxic metal ions ...Missing: peer- | Show results with:peer-
[4]
Chelation Therapy Procedure - Cleveland Clinic
Feb 12, 2025 · Chelation therapy is a treatment for heavy metal poisoning that removes metals from your body to prevent them from harming you.
[5]
EDTA chelation therapy for cardiovascular disease: a systematic ...
The best available evidence does not support the therapeutic use of EDTA chelation therapy in the treatment of cardiovascular disease.
[6]
Chelation Therapy and Cardiovascular Disease - NIH
In fact, a 2002 Cochrane systematic review on the role of chelation therapy in coronary heart disease concluded that the existing body of work on chelation ...
[7]
Alfred Werner – Facts - NobelPrize.org
In 1893 Alfred Werner contributed to the understanding of molecular structures of inorganic substances—chemical compounds that do not contain carbon.
[8]
Alfred Werner: the well-coordinated chemist - Chemistry World
Feb 25, 2013 · In 1913, Alfred Werner received the Nobel prize for discoveries in the field of inorganic chemistry. Most previous Nobel chemistry awards ...
[9]
Alfred Werner – Biographical - NobelPrize.org
For his work on it Werner was awarded the Nobel Prize for Chemistry for 1913. Werner was corresponding member of the Royal Society of Sciences (Königliche ...
[10]
https://www.degruyterbrill.com/document/doi/10.1515/pac-2014-0504/html
[11]
Alfred Werner (1866–1919) – ETH Library
Alfred Werner was the first to recognise the fundamental principle of complex chemistry and formulated the conceptual bases of coordination compounds.
[12]
Alfred Werner – Nobel Prize in Chemistry 1913 - UZH
Alfred Werner revolutionized inorganic chemistry one night with a stroke of genius – and without conducting a single experiment.
[13]
Some Linguistic Detail on Chelation
Jan 1, 1998 · The history of the word chelate is traced from its original Greek mean- ing through the Latin language to its anglicized form, chela. This ...
[14]
[PDF] Chelate Effect and Its Thermodynamic Origin | Dalal Institute
The term 'chelates' was first proposed by Morgan and Drew in 1920 for the cyclic structure arising from the assembly of metals with organic ligands. The ...<|separator|>
[15]
https://www.researchgate.net/publication/396737295_Ferdinand_Munz_EDTA_and_40_Years_of_Inventions
[16]
Ferdinand Münz: EDTA and 40 years of inventions - IsisCB Explore
This paper describes the life and accomplishments of the Austrian chemist Ferdinand Münz, who synthesized EDTA (ethylenediaminetetraacetic acid) in 1935.
[17]
The Austrian Scientist Time Forgot Because He Was a Jew
Jan 28, 2018 · The Austrian chemist Ferdinand Münz (1888-1969) invented and synthetized EDTA (ethylenediaminetetraacetic acid) in 1935 and was also the ...
[18]
British anti-Lewisite (dimercaprol): an amazing history - PubMed
During World War II, BAL minimized the risk to the Allied infantry of injury or death from Lewisite, a very potent arsenic-based chemical warfare agent. Once ...
[19]
British anti-Lewisite (dimercaprol): An amazing history - ScienceDirect
Larson6 reported that BAL was considered 1 of the 5 outstanding contributions to medicine developed as a result of World War II, although supporting data were ...
[20]
New developments and controversies in iron metabolism and ... - NIH
Many of the controversies in the use of chelating drugs arise from the different influences and priorities for use by the regulatory authorities, clinicians ...
[21]
Succimer: Uses, Interactions, Mechanism of Action | DrugBank Online
Succimer is an orally active, heavy metal chelating agent. It forms water soluble chelates and, consequently, increases the urinary excretion of lead. Succimer ...Identification · Pharmacology · Interactions · References
[22]
Chelators for Treatment of Iron and Copper Overload: Shift from Low ...
Nov 17, 2021 · Essentially, principles of classical coordination chemistry, which goes back to Alfred Werner, have been used for this purpose [11]. This ...
[23]
Edetate calcium disodium: Uses, Interactions, Mechanism of Action
Aug 25, 2018 · Edetate calcium disodium is a chelating agent used to treat lead poisoning ... Edetate calcium disodium was granted FDA approval on 16 July 1953.
[24]
Ethylenediaminetetraacetic Acid (EDTA) - StatPearls - NCBI Bookshelf
Jun 26, 2023 · ... EDTA as a valuable agent in managing lead toxicity. ... Currently, EDTA is FDA-approved for the treatment of lead poisoning in adults and children ...
[25]
Lead Toxicity and Chelation Therapy - U.S. Pharmacist
May 15, 2015 · In most cases, exposure can be prevented or at least minimized and eliminated. There are four available agents used to treat lead toxicity: ...
[26]
Antidotes in Depth | Goldfrank's Toxicologic Emergencies, 10e
Work on using CaNa2EDTA for lead toxicity began in the 1950s. At the same time, investigation into the uses of EDTA for the reversal of cardiovascular disease ...Missing: human | Show results with:human
[27]
Lightening the Lead Load in Children - AAFP
Aug 1, 2000 · Because of the toxicity of penicillamine, the AAP recommends that this agent be used to treat lead poisoning “only when unacceptable reactions ...
[28]
What Is a Chelate in Chemistry? - ThoughtCo
Jul 3, 2019 · Chelation, according to the IUPAC, involves the formation of two or more separate coordinate bonds between the ligand and central atom. The ...
[29]
https://chem.libretexts.org/Bookshelves/Inorganic_Chemistry/Supplemental_Modules_and_Websites_(Inorganic_Chemistry)/Coordination_Chemistry/Complex_Ion_Equilibria/Stability_of_Metal_Complexes_and_Chelation
[30]
Stability of Metal Complexes and Chelation - Chemistry LibreTexts
Jun 30, 2023 · When a bidentate ligand such as ethylenediamine binds to a metal such as Ni2+, a five-membered ring is formed. A metal-containing ring like that ...
[31]
E4a: Stepwise Association Constants - Chemistry LibreTexts
Nov 2, 2020 · This table provides K_i and β_i values for metal-ligand complexes, arranged by ligand, from Martell and Smith, at 25°C and zero ionic strength.
[32]
[PDF] STABILITY CONSTANTS AND THEIR MEASUREMENT
The log β values for [Ni(NH3)]2+ and [Ni(en)3]2+ complexes are 8.6 and 18.6, respectively; which in turn confirms the higher stability of the chelate one.
[33]
9.1.5: Thermodynamic Stability and Chelate Effect
Jan 17, 2025 · The Chelate Effect is that complexes resulting from coordination with the chelating ligand is much more thermodynamically stable than complexes ...
[34]
The Chelate Effect Studied by Calorimetry, Potentiometry, and ...
Publication History. Published. online 1 May 2002. Published. in issue 1 February 1963. research-article. © American Chemical Society. Request reuse permissions ...Missing: verification | Show results with:verification
[35]
20.12: Thermodynamic Aspects - The Irving-Williams Series
Jan 15, 2023 · In the case of 1,2-diaminoethane (en), the first step-wise stability constants (logK1) for M(II) ions are shown below. logen.gif. The Irving- ...
[36]
[PDF] Stability Constant of Metal Ligand and Complex
The study confirms that solvent polarity and temperature exert notable effects on stability, where polar solvents and lower temperatures generally stabilize ...
[37]
E5: Acid Dissociation Constants of Organics - Chemistry LibreTexts
Jun 16, 2024 · The following table provides pK a and K a values for selected weak acids. All values are from Martell, AE; Smith, RM Critical Stability Constants, Vols. 1–4.
[38]
Speciation diagrams for (a) Cu(II) and (b) Ni(II) as a function of pH...
Download scientific diagram | Speciation diagrams for (a) Cu(II) and (b) Ni(II) as a function of pH for the free metal cation and for the 1:0.5 metal:EDTA ...
[39]
Iron and Chelation in Biochemistry and Medicine: New Approaches ...
These metal ions and especially iron play a central role in important physiological processes such as oxygen transport and utilization, respiration and also ...Iron And Chelation In... · 2.2. Iron In Heme... · 4.3. Transferrin Iron...
[40]
The interplay between iron and oxygen homeostasis with a ... - NIH
At the systemic level, iron deficiency reduces arterial oxygen content by restricting hemoglobin concentration, which when severe may result in global hypoxia ( ...
[41]
Exploiting bacterial iron acquisition: siderophore conjugates - NIH
Siderophores are chelators synthesized by bacteria and fungi to sequester iron, which is essential for virulence and pathogenicity.
[42]
Siderophores: Importance in bacterial pathogenesis and ...
Siderophores are low-weight, high-affinity iron chelating molecules produced in response to iron deficiency by Gram-positive and Gram-negative bacteria.
[43]
Structural classification of zinc fingers | Nucleic Acids Research
Abstract. Zinc fingers are small protein domains in which zinc plays a structural role contributing to the stability of the domain.
[44]
Structures and biological functions of zinc finger proteins and their ...
Jan 9, 2022 · Here, we summarize multiple functions and recent research of zinc finger proteins in HCC tumorigenesis and progression.
[45]
Glutathione Is a Key Player in Metal-Induced Oxidative Stress ...
Second, GSH contains one cysteine molecule forming the centre of its biological functions in chelation but also in the antioxidative defense and redox control.
[46]
Different roles of glutathione in copper and zinc chelation in ...
For example, glutathione can function as a principal copper and zinc chelator in the cell because it can bind different transition metal ions with high ...
[47]
The Importance and Essentiality of Natural and Synthetic Chelators ...
For example, natural chelators such as transferrin and chelator–iron complexes such as haem play major roles in iron metabolism and human physiology. Similarly, ...
[48]
Iron and Chelation in Biochemistry and Medicine: New Approaches ...
Deferiprone, deferoxamine, deferasirox and other chelating drugs can offer therapeutic solutions for most diseases associated with iron metabolism.
[49]
Effect of humic substances on the fraction of heavy metal and ... - NIH
May 16, 2024 · The main constituents of HS include fulvic acid (FA) and humic acid (HA), which are natural components of soil and pose no harm to the soil ...
[50]
Molecular determinants of humic and fulvic acids in enhancing ...
Oct 1, 2025 · This study investigated the efficacy of humic (HA) and fulvic acids (FA) in enhancing the availability of Fe, Mn, Zn, and Cu across six ...
[51]
The influence of humic and fulvic acids on Cd bioavailability to ...
Dec 1, 2020 · Humic and fulvic like acids influenced plant growth and metal availability. Abstract. The soil cadmium (Cd) contamination is a ubiquitous ...
[52]
Measurement of complexation properties of humic and fulvic acids in ...
Measurement of complexation properties of humic and fulvic acids in natural waters with lead and copper ion-selective electrodes
[53]
The Organic Complexation of Iron in the Marine Environment
Iron (Fe) is an essential micronutrient for marine organisms, and it is now well established that low Fe availability controls phytoplankton productivity, ...
[54]
Saccharides enhance iron bioavailability to Southern Ocean ... - PNAS
Dec 15, 2010 · Here, we report on the pivotal role of saccharides—which may act like an organic ligand—in enhancing iron bioavailability to a Southern Ocean ...
[55]
Iron bioavailability to phytoplankton: an empirical approach - Nature
Oct 28, 2014 · Phytoplankton are often limited by iron in aquatic environments. Here we examine Fe bioavailability to phytoplankton by analyzing iron uptake from various Fe ...
[56]
Utilization of iron bound to strong organic ligands by plankton ...
During short-term experiments, plankton took up Fe bound to the siderophores desferrioxamine B and E, microbial Fe chelates with a high affinity for Fe. Uptake ...
[57]
Biobased biodegradable chelating agents enhance coupled ex situ ...
Aug 21, 2025 · Chelating agents enhance mineral dissolution through a combined effect of proton attack and metal ion complexation. The presence of chelating ...
[58]
Transformation of Natural Organic Matter in Simulated Abiotic Redox ...
Nov 25, 2024 · In this work, we investigate the changes in the molecular composition of NOM during redox fluctuations as well as the impact of these changes on ...
[59]
A unifying model for Neoproterozoic–Palaeozoic exceptional fossil ...
Dec 17, 2014 · Here geochemical analyses of the Gaojiashan fossil Conotubus hemiannulatus show that pyrite precipitation was fuelled by the degradation of ...<|control11|><|separator|>
[60]
Chelants in water treatment: An overview - Waterline
Oct 8, 2023 · Chelants, also known as chelating agents, are organic compounds that can form stable, water-soluble complexes with metal ions.
[61]
chelant in boiler feed water - Hebei Think-Do Chemicals Co., Ltd.
Oct 19, 2024 · Chelating agents work by sequestering metallic ions that contribute to scale and corrosion. For instance, calcium and magnesium ions can be ...Missing: laundry | Show results with:laundry
[62]
How is scale detrimental to boilers? (Pt. 2) - Complete Water Solutions
Oct 31, 2017 · Chelant is a chemical that helps keep the hardness in the boiler water dissolved so that it does not crystallize on heating surfaces. Chelants ...Missing: chelators laundry
[63]
Environmental risk assessment of phosphonates, used in domestic ...
They are used in numerous technical and industrial applications as chelating agents and scale inhibitors.
[64]
What Is Chelation? - Safe Household Cleaning
Oct 2, 2018 · Chelating agents are widely used in domestic cleaning products to prevent metal ions naturally found in water from forming soap scum.
[65]
Advanced Cleaning Mechanisms: Chelation - TechNotes
Mar 22, 2022 · Chelators can generally be classified as hard chelants which would be EDTA, citric acid and sodium gluconate and soft chelants which would be ...
[66]
Complexing agents and phosphonates | STOCKMEIER Chemie
In detergent formulations, complexing agents and phosphonates can be used as water softeners. In addition, they serve in combination to inhibit corrosion ...
[67]
Environmental fate and microbial degradation of ...
EDTA is rather recalcitrant towards biological and chemical degradation in the environment and there is increasing pressure to replace it by other powerful ...
[68]
(PDF) EDTA: The chelating agent under environmental scrutiny
Aug 9, 2025 · It is concluded that EDTA behaves as a persistent substance in the environment and that its contribution to heavy metals bioavailability and ...
[69]
Understanding and Applying Chelated Fertilizers Effectively Based ...
Chelated fertilizers use a ligand to protect micronutrients, improving their bioavailability, especially in soils with pH > 6.5, where they are often needed.Missing: alkaline | Show results with:alkaline
[70]
Iron nutrition in agriculture: From synthetic chelates to biochelates
Mar 15, 2023 · For soil applications, Fe fertilizers are based on Fe chelated with aminocarboxylate synthetic ligands (e.g. HEDTA, EDTA, DTPA, EDDHA), which ...
[71]
Chemical Stability of the Fertilizer Chelates Fe-EDDHA and Fe ... - NIH
Mar 30, 2021 · The changes in the content of micronutrient ions and Fe-EDDHA and Fe-EDDHSA chelates in an aqueous medium at different pH values were studied.
[72]
Nano and chelated iron fertilization influences marketable yield ...
Nov 8, 2023 · Increasing Fe fertilization decreased the leaf SPAD readings. The total fruit yield of tomato was 1.6 to 1.8 times higher under the chelated- ...
[73]
Efficacy of Chelated Micronutrients in Plant Nutrition
Chelation enhances micronutrient effectiveness by forming stable complexes, aiding plant stability and uptake, and alleviating deficiencies. Both synthetic and ...
[74]
CE Certification Iron Chelated Organic Fertilizer - Accio
Rating 5.0 (109) Field trials showing 15–25% yield improvement in chlorosis-affected crops (e.g., grapes, citrus) indicate reliability. Cost-Efficiency Factors. Calculate ...<|control11|><|separator|>
[75]
Relative Bioavailability of Trace Minerals in Production Animal ... - NIH
The average weight of the hydrolysed amino acids must be approximately 150 and the resulting molecular weight of the chelate must not exceed 800. The minimum ...
[76]
[PDF] PROTEINATED AND CHELATED MINERAL COMPLEXES
Dec 8, 2002 · The primary chelated minerals used in animal feed are the trace elements iron, manganese, cobalt, copper, and zinc. These “Transitional Elements ...
[77]
Review: Bioavailability of trace elements in farm animals
Trace element supplements for animal nutrition must be approved as feed additives within the European Union. However, the applicable Regulation (EC) No.
[78]
Worldwide Research Trends for Chelates in Animal Science
Jul 21, 2023 · The application of chelated trace minerals (CTM) in livestock nutrition is an expanding research area with a focus on the health and quality ...
[79]
[PDF] STABILITY OF TRACE MINERALS: DOES THE SOURCE MATTER?
“In the animal nutrition industry, various chelated Zn sources have been marketed for their claimed superior bioavailability over traditional sulfates.
[80]
[PDF] EDTA-assisted phytoremediation of cadmium contaminated soil by ...
This research indicated that low EDTA dosage (1.5 mmol/kg) was efficient in assisting remediation of Cd contaminated soil by S. nigrum L. and could lessen ...
[81]
EDTA-assisted phytoextraction of lead and cadmium by ...
Jan 21, 2019 · The aim of this study was to assess EDTA-assisted Pb and Cd phytoextraction potential of locally grown Pelargonium hortorum and Pelargonium zonale.Missing: remediation | Show results with:remediation
[82]
[PDF] STUDY ON EDTA-ASSISTED PHYTOREMEDIATION OF HEAVY ...
This study evaluates Portulaca oleracea's ability to remove heavy metals from soil, with EDTA enhancing this process. Portulaca oleracea accumulated cadmium ...
[83]
Effect of ultrasound-assisted EDTA and citric acid washing on heavy ...
Sep 7, 2023 · Citric acid (CA), both an organic acid and a chelation agent, has been extensively explored in HM washing because it is biodegradable and does ...
[84]
[PDF] A comparative study on the efficacy of conventional and green ...
EDDS shows superior performance for heavy metal removal, followed by MGDA, GLDA, and EDTA. MGDA has the broadest pH range, and EDDS is the most biodegradable.
[85]
Biodegradable chelating agents for enhancing phytoremediation
Mar 1, 2024 · Biodegradable chelators can be degraded by microorganisms into harmless and non-toxic compounds, reducing their potential toxicity and ...
[86]
EDTA as a legacy soil chelatant: a comparative study to a ... - NIH
However, EDTA, like most synthetic chelatants, has several disadvantages: (i) it has a high cost, (ii) is poorly biodegradable, (iii) can lead to secondary ...
[87]
In Situ Flushing & Soils Washing Technologies for Superfund Sites
~ The single sample will be "washed" with EDTA solution In the laboratory to deter- mine the effectiveness of the EDTA chelating process. Ten gram (lOg) ...
[88]
Kinetics of Cu, Pb and Zn removal during soil flushing with washing ...
May 12, 2021 · This paper presents the first tests of Cu (7875 mg/kg), Pb (1414 mg/kg) and Zn (566 mg/kg) removal from contaminated soil with sewage-sludge–derived washing ...
[89]
Soil washing with biodegradable chelating agents and EDTA
However, EDTA is poorly biodegradable and persists in the environment. Its widespread use has led to background concentrations of EDTA in European surface ...
[90]
[PDF] Cost Estimation of Electrokinetic Soil Remediation for Removal of ...
The total operating cost was about US$ 110 to US$ 1006 per cubic meter of treated soil including enhancers cost. We believe the chelating enhanced ...
[91]
Cost–benefit calculation of phytoremediation technology for heavy ...
Sep 1, 2016 · Results of the present study can help determine the most expensive procedure for phytoremediation, favoring subsequent work on reducing costs.
[92]
Cost and health benefit analysis of remediation alternatives for the ...
Apr 15, 2023 · This study presents a field-scale assessment of the health benefit of soil remediation technologies, which were seldom considered in the previous cost–benefit ...
[93]
Deferoxamine - StatPearls - NCBI Bookshelf - NIH
May 22, 2023 · Deferoxamine (DFO or DFOA) is FDA approved to treat iron overload, either acute or chronic. The definition of iron overload is serial ferritin ...Indications · Mechanism of Action · Administration · Monitoring
[94]
Provocative chelation with DMSA and EDTA - NIH
A metal chelating agent given orally, DMSA may mobilise and enhance the excretion of lead from the storage sites in the body that are most directly relevant to ...
[95]
Chelation Therapy - Medical Clinical Policy Bulletins - Aetna
There is insufficient evidence to support the use of chelation therapy for prevention or treatment of cardiovascular disease. Chelation therapy for ...Dosage And Administration · Chronic Iron Overload · Cardiovascular Diseases<|separator|>
[96]
CG-MED-90 Chelation Therapy - Healthy Blue
Adults: In the presence of severe encephalopathy or when blood lead levels exceed 100 µg/dL, chelation should start with dimercaprol (BAL) followed in 4 hours ...
[97]
DMSA administration to patients with alleged mercury poisoning ...
DMSA-treatment resulted in an average increase in urinary mercury excretion by 65% and a decrease in blood mercury levels of 0.04 microgram/L/day. At the check- ...
[98]
Mercury Toxicity Medication: Chelating Agents, Gastrointestinal ...
Feb 26, 2024 · DMSA is used in inorganic and organic mercurials. It is considered superior to penicillamine because it has fewer adverse effects. Because of ...
[99]
Efficacy of Deferoxamine in Preventing Complications of Iron ...
Sep 1, 1994 · The average prescribed dose was about 42 mg per kilogram of body weight per day (range, 27 to 65), to be taken at least five days each week. The ...
[100]
Long-term Efficacy of Deferoxamine Iron Chelation Therapy in ...
We conclude that long-term deferoxamine iron chelation therapy is effective not only in retarding but, in some cases, even reversing organ damage caused by ...
[101]
Lead | Medical Management Guidelines | Toxic Substance Portal
Removal from exposure may be followed by chelation therapy in patients with blood lead levels between 45 and 70 µg/dL. Chelation therapy is required in patients ...Missing: DMSA | Show results with:DMSA
[102]
Gd-DOTA, a potential MRI contrast agent. Current status ... - PubMed
Indeed, as a result of the macrocyclic nature of the DOTA ligand, Gd-DOTA appears very stable, demonstrating a calculated conditional stability constant of 10( ...
[103]
Design and synthesis of chiral DOTA-based MRI contrast agents ...
Nov 16, 2023 · Gd-DOTA is one of the most stable complexes among the clinically used GBCAs, and it is used as a benchmark in our analysis. We found that its ...
[104]
Gadolinium contrast agents- challenges and opportunities of a ...
The most stable and least toxic ionic-macrocyclic gadolinium-based contrast agents, such as gadoterate meglumine (Gd-DOTA), are recommended for clinical use, ...
[105]
Recent Advances in Zirconium-89 Chelator Development - PMC - NIH
This review focuses on recent advances in zirconium-89 chelation chemistry and will highlight the rapidly expanding ligand classes that are under investigation ...
[106]
Bifunctional octadentate pseudopeptides as Zirconium-89 chelators ...
May 6, 2024 · Zirconium-89 (89Zr) has been extensively investigated as a useful radionuclide to employ as immuno-PET imaging tool. The half-life of 89Zr (3.27 ...
[107]
promising metallodrugs in the battle against cancer - RSC Publishing
Jul 31, 2025 · 1 Platinum metallodrugs approved for cancer treatment. It has been proved that one of the main molecular targets of platinum drugs is DNA, where ...
[108]
A review on metal complexes and its anti-cancer activities
Metallodrugs, which are more effective and less toxic than platinum-based drugs and can treat drug-resistant cancer cells, are the focus of this review. Here, ...
[109]
Metals in Cancer Research: Beyond Platinum Metallodrugs
Feb 7, 2024 · The discovery of the medicinal properties of platinum complexes has fueled the design and synthesis of new anticancer metallodrugs endowed with unique modes of ...
[110]
Metallo-Drugs in Cancer Therapy: Past, Present and Future - NIH
Metallodrugs are unique: Opportumities and challenges of discovery and development. ... Phase I –preliminary phase II trial of iproplatin, a cisplatin analogue.
[111]
Comparison of the Effects of Inorganic or Amino Acid-Chelated Zinc ...
In conclusion, amino acid-chelated zinc, particularly ZnMet, had the best effect, which could improve growth in vitro and increase growth performance while ...
[112]
Comparison of zinc bioavailability in zinc-glycine and zinc ... - Frontiers
Nov 16, 2022 · The objective of this study was to compare the bioavailability of Zn from zinc-glycine (Zn-Gly) and zinc-methionine (Zn-Met) as compared ...
[113]
Safety and efficacy of zinc chelate of methionine sulfate for all ...
Jun 8, 2017 · The authors estimated the zinc bioavailability from zinc methionine complex relative to zinc sulfate as > 100% under all experimental diets.
[114]
21 CFR Part 573 -- Food Additives Permitted in Feed and Drinking ...
(2) Adequate mixing directions to ensure that the chelated trace-mineral mix is uniformly blended throughout the feed. § 573.380 Ethoxyquin in animal feeds.
[115]
Chelated Minerals: Types, Benefits, and Recommendation - Healthline
May 20, 2020 · Though they're often said to be absorbed better than regular mineral supplements, the current research is mixed.
[116]
A Review of Mineral Absorption with Special Consideration of ...
The absorption and nutritional value of mineral amino acid chelates has not been scientifically studied in humans, with one exception – Ferrochel – a patented ...<|control11|><|separator|>
[117]
Trace Minerals and Livestock: Not Too Much Not Too Little - PMC
As previously indicated, mineral supplementation given to livestock reared under intensive production is considered relatively safe because the high degree of ...
[118]
Reducing the risk of over-supplementing minerals in dairy cows
Study findings suggest that over-supplementing trace minerals is a widespread challenge threatening animal health, performance, environmental.
[119]
The facts and fictions of chelation therapy | Dr. Ronald Hoffman
Feb 17, 2014 · In the 1950s and 1960s, several clinicians began to observe that patients treated for lead poisoning with IV EDTA experienced improvements in ...
[120]
Chelation 60 Years - Townsend Letter
May 1, 2013 · Almost 60 years after the first discovery that EDTA chelation therapy could be effective in the treatment of heart and blood vessel diseases, ...
[121]
Chelation Therapy: A New Look at an Old Treatment for Heart ... - NIH
May 26, 2016 · Chelation therapy was first used in the early 20th century to treat metal poisoning. ... One chelator, calcium EDTA, is FDA approved to treat lead ...
[122]
Why the NIH Trial to Assess Chelation Therapy (TACT) Should Be ...
It reverses atherosclerosis by reducing “free radical” production dependent upon iron.[105]. And more. All in all, according to Elmer Cranton, a past ...
[123]
A Timeline for EDTA Chelation Therapy as a Treatment for Vascular ...
Oct 18, 2013 · Alfred Werner proposed the theory of metal-ligand binding (“the pincer-like fashion”), which provided the foundation for modern chelation ...<|control11|><|separator|>
[124]
[PDF] Chelation therapy - กระทรวงสาธารณสุข
Chelation removes this calcium. Leading chelation therapy proponent Elmer Cranton proposes in his 1990 book, Bypassing Bypass,60 that. EDTA blocks the ...
[125]
Chelation Therapy: A Natural Detox for Better Health
1. Detoxification of Heavy Metals · 2. Improved Cardiovascular Health · 3. Reduced Inflammation · 4. Enhanced Energy and Mental Clarity · 5. Support for Chronic ...
[126]
The Power of Chelation Therapy - Angel Longevity Medical Center
Chelation therapy represents a valuable tool in the realm of integrative medicine, offering potential benefits for detoxification, cardiovascular health, and ...
[127]
Design of the Trial to Assess Chelation Therapy - PubMed Central
TACT has randomized and will follow 1708 patients for an average of approximately 4 years. The primary endpoint is a composite of all cause mortality, ...
[128]
https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.113.000663
[129]
Chelation Therapy in Patients With Cardiovascular Disease
Mar 1, 2022 · One recent meta‐analysis found no evidence of a difference between EDTA chelation and placebo for CVD treatment; however, only one study had a ...
[130]
Edetate Disodium–Based Chelation for Patients With a Previous ...
Aug 14, 2024 · In 2013, the Trial to Assess Chelation Therapy (TACT) reported an 18% relative risk reduction in cardiovascular disease (CVD) events with ...
[131]
Chelation for autism spectrum disorder (ASD) - James, S - 2015
May 11, 2015 · Currently no clinical trial evidence suggests that pharmaceutical chelation is an effective intervention for ASD. Given prior reports of serious ...Missing: Alzheimer's | Show results with:Alzheimer's
[132]
Chelation for autism spectrum disorder (ASD) - PMC - PubMed Central
This review found no high‐quality evidence to suggest that chelation is an effective treatment for improving ASD symptoms. Cochrane reviews typically avoid ...
[133]
Deaths Associated with Hypocalcemia from Chelation Therapy - CDC
Mar 3, 2006 · This report describes three deaths associated with chelation-therapy--related hypocalcemia that resulted in cardiac arrest.
[134]
Deaths resulting from hypocalcemia after administration of edetate ...
From 2003 to 2005, deaths of 3 individuals as a result of cardiac arrest caused by hypocalcemia during chelation therapy were reported.
[135]
Chelation Therapy: EDTA and Other Chemicals, Benefits, Side Effects
Apr 9, 2018 · Chelation therapy removes heavy metals from the bloodstream. It's a very effective treatment for heavy metal poisoning.
[136]
Chelation Therapy | Senior Health Services | Hartford HealthCare | CT
Side effects of chelation treatment may include headaches, rash, nausea, vomiting, and abdominal pain. The treatment may remove vital minerals from the body ...Missing: depletion | Show results with:depletion
[137]
Chelation therapy for heart disease: Does it work? - Mayo Clinic
Mar 18, 2025 · Chelation therapy doesn't seem to be an effective treatment for heart disease. Chelation therapy has long been used as a treatment for mercury and lead ...
[138]
Chelation Therapy: Purpose, Procedure, and Side-Effects - WebMD
Sep 20, 2023 · The most common side effect is burning in the area where you get the IV. You might also experience fever, headache, and nausea or vomiting.
[139]
Questions and Answers on Unapproved Chelation Products - FDA
Feb 2, 2016 · FDA has never approved any chelation product for OTC use for any health condition. All FDA-approved chelation products require a prescription ...Missing: off- label
[140]
FDA Warning Targets OTC Chelation Products - JAMA Network
Nov 17, 2010 · “The FDA is concerned that unapproved over-the-counter chelation products are dangerously misleading because they target patients and caregivers ...
[141]
Chelation therapy offers small, if any, benefit for heart disease
Mar 26, 2013 · Each treatment costs $75 to $125, and people often undergo dozens of ... All in all, a treatment course can exceed $5,000—and it isn't ...
[142]
How Much Does IV Chelation Therapy Cost? (2025) - Thervo
Apr 15, 2025 · IV chelation therapy costs $100 to $300 per session, or $500 to $6000 on average for an entire treatment series.
[143]
Kinetic study of acid dechelation of some vanadium(V)
Kinetic studies of the acid hydrolysis of vanadium(V) complexes of ethylenediaminetetra-acetic acid (H4edta), ethylenediamine-N,N′-diacetic acid (H2edda) ...
[144]
The Effect of pH on the Stability of EDTA Chelates - Wellyou Tech
Sep 15, 2025 · However, the stability of EDTA complexes is strongly influenced by pH conditions. Under acidic or alkaline environments, chelated metal ions may ...
[145]
Accelerated de-chelation of EDTA-metal complexes: A novel and ...
Aug 15, 2024 · A method to rapidly de-chelate the EDTA-metal complexes through the facile chilling process (1 – 3 h) that accelerates the separation of EDTA and metal ions.
[146]
Dechelation of Cd-EDTA complex and recovery of EDTA from ...
In this study, sulfide precipitation using Na 2 S was more effective in the dechelation of Cd-EDTA solution with a pH of 4–10 as the sodium sulfide dosage ...
[147]
Iron release from ferritin by flavin nucleotides - ScienceDirect.com
The ferritin iron core is a relatively stable entity with a very low iron dissociation rate in the absence of reducing agents. Several pathways of iron release ...
[148]
Reductive Mobilization of Iron from Intact Ferritin: Mechanisms and ...
Nov 5, 2018 · In vitro iron mobilization from ferritin can be achieved using different reducing agents, capable of easily reducing the ferritin iron core.Missing: dissociation | Show results with:dissociation
[149]
Ultra-inert lanthanide chelates as mass tags for multiplexed ... - NIH
Nov 13, 2024 · The kinetic inertness of the chelates was tested by acid-assisted dechelation under pseudo-first-order conditions with excess HCl, ...
[150]
High Thermodynamic Stability and Extraordinary Kinetic Inertness of ...
Dec 30, 2002 · The trans-III ring conformation is thermodynamically the most stable conformation in metal complexes of cyclam derivatives.1a, 43 Therefore, the ...
[151]
Dechelation of Cd-EDTA complex and recovery of EDTA ... - PubMed
A series of batch experiments were performed to explore the dechelation of heavy metal-EDTA complexes and the recovery of EDTA from simulated soil-washing ...Missing: hydrolysis | Show results with:hydrolysis<|separator|>
[152]
Drawbacks of Dialysis Procedures for Removal of EDTA - PMC - NIH
Jan 18, 2017 · We report here that dialysis protocols, even as extensive as those typically employed for protein refolding, may not effectively remove EDTA.
[153]
Gadolinium Retention: A Research Roadmap from the 2018 NIH ...
Sep 11, 2018 · Because unchelated gadolinium ions are considerably more toxic than the gadolinium chelates used in GBCA, the primary focus of speciation is to ...
[154]
Photocatalysis for Heavy Metal Treatment: A Review - ResearchGate
Apr 20, 2025 · Photocatalysis, an emerging advanced catalytic oxidation technology, uses light energy as the only source of energy. It is a clean new ...
[155]
Search for chlorophyll degradation enzyme, Mg-dechelatase, from ...
We previously demonstrated that the presence of a smaller metal-chelating substance (MCS) is required for the Mg-dechelation reaction using Chlide as the native ...
[156]
Impact of Treatment With Chelating Agents Depends on the Stability ...
Oct 22, 2018 · Dechelation of GBCA may result in toxic effects caused by interference with biological processes. Unchelated Gd ions can compete with ...
[157]
Electrodialysis for metal removal and recovery: A review
May 1, 2022 · Electrodialysis (ED) is an emerging method to remove and recover metals. Selective ED is key to recover metals from matrice and mixtures.